Table 8. Estimated relative risk of... | American Society of Hematology

Table 8.

Estimated relative risk of death from any cause after complete remission, by postremission treatment arm and SWOG cytogenetic risk status

Risk status	All treatment arms combined (n = 253)		Allo-BMT (n = 84)	Autologous BMT (n = 83)		Consolidation (n = 86)
Risk status	RR^8-150	CI	RR^8-151	RR^8-151	CI	RR^8-151	CI
Favorable	1.00	—	1.00	0.70	0.25-2.01	2.04	0.82-5.05
Intermediate	1.34	0.57-3.14	1.00	1.43	0.80-2.57	0.70	0.37-1.31
Unfavorable	1.73	0.66-4.55	1.00	2.22	1.01-4.87	1.82	0.83-3.98

Risk status	All treatment arms combined (n = 253)		Allo-BMT (n = 84)	Autologous BMT (n = 83)		Consolidation (n = 86)
Risk status	RR^8-150	CI	RR^8-151	RR^8-151	CI	RR^8-151	CI
Favorable	1.00	—	1.00	0.70	0.25-2.01	2.04	0.82-5.05
Intermediate	1.34	0.57-3.14	1.00	1.43	0.80-2.57	0.70	0.37-1.31
Unfavorable	1.73	0.66-4.55	1.00	2.22	1.01-4.87	1.82	0.83-3.98

AlloBMT indicates allogeneic bone marrow transplantation; RR, relative risk; CI, confidence interval.

Estimated RRs for risk status groups, all treatment arms combined.

Estimated RRs for postremission treatment arms within risk status group.